CCA
CL icon

Cypress Capital Advisors’s Colgate-Palmolive CL Stock Holding History

Cypress Capital Advisors’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$626K Sell
6,825
-173
-2% -$15.1K 0.26% 52
2026
Q1 		$596K Buy
6,998
+3,952
+130% +$352K 0.32% 50
2025
Q4 		$241K Sell
3,046
-4,143
-58% -$325K 0.13% 68
2025
Q3 		$575K Sell
7,189
-274
-4% -$23.4K 0.33% 51
2025
Q2 		$678K Buy
7,463
+365
+5% +$33.3K 0.42% 46
2025
Q1 		$665K Buy
+7,098
New +$636K 0.46% 46

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Cypress Capital Advisors's CL Position: Q2 2026 in Review

Cypress Capital Advisors reduced its Colgate-Palmolive (CL) stake by 2.5% in Q2 2026, selling an estimated $15.1K and leaving 6,825 shares worth $626K. The position accounts for 0.26% of the portfolio, ranked #52.

Cypress Capital Advisors first reported a position in CL in Q1 2025 and has held it in 6 quarters since. The position peaked at $678K in Q2 2025. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Cypress Capital Advisors held 6,825 shares of Colgate-Palmolive worth $626K as of Q2 2026.
  • Cypress Capital Advisors sold 173 Colgate-Palmolive shares in Q2 2026, an estimated $15.1K.
  • Colgate-Palmolive made up 0.26% of Cypress Capital Advisors's portfolio in Q2 2026, its #52 holding.
  • Cypress Capital Advisors first reported a position in Colgate-Palmolive in Q1 2025 and has held it in 6 quarters since.
  • Cypress Capital Advisors's Colgate-Palmolive position peaked at $678K in Q2 2025.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Cypress Capital Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.